NCT00059605View on ClinicalTrials.gov

Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Lung Cancer
Interventions
GENETIC

DOTAP:Chol-fus1

Infusion of DOTAP:Chol-fus1 by vein once every 3 weeks.

Trial Locations (1)

77030

University of Texas M.D. Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00059605 - Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer | Biotech Hunter | Biotech Hunter